Institutional investors purchased a net $2.0 million shares of STJ during the quarter ended June 2015 and now own 88.62% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.